Table 5.

Median prices for 30-days treatment with diabetes medicines, by foreign exchange rates, and purchasing power parity adjustment.

Countries	Metformin 500 mg		Metformin 850 XR		Gliclazide 80 mg	Insulin 100 IU/ml
	XR*	PPP**	XR*	PPP**	XR*	XR*	PPP**
Afghanistan	1.92	40.28	–	–	–	–	–
Armenia	7.38	1479.87	–	–	–	–	–
Bangladesh	4.31	137.18	4.32	137.63	2.52	2.52	80.21
Egypt	1.07	3.64	0.67	2.29	0.71	0.71	2.44
Georgia	5.76	5.64	–	–	–	–	–
India	0.02	0.39	2.38	42.92	1.71	1.71	30.79
Jordan	4.23	1.35	–	–	–	–	–
Nepal	0.39	13.39	0.15	5.25	0.04	0.04	1.49
Oman	2.79	0.45	2.16	0.34	4.82	4.82	0.77
Pakistan	0.83	25.71	0.73	22.79	0.88	0.88	27.18
Qatar	4.53	8.48	–	–	–	–	–
Russia	2.26	52.99	2.54	59.59	–	–	–
Saudi Arabia	201.60	306.43	–	–	–	–	–
Sri Lanka	0.44	21.88	–	–	0.61	0.61	30.50
Tanzania	5.93	4334.17	5.27	3852.59	–	–	–
United Arab Emirates	1.76	0.04	–	–	–	–	–

*XR, price in US$ when converted from local currency using foreign exchange rates.

**PPP, price in US$ when converted from local currency using purchasing power parity.